LCS
LLY icon

Levin Capital Strategies’s Eli Lilly LLY Stock Holding History

Levin Capital Strategies’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-415
Closed -$323K – 250
2024
Q1 		$323K Hold
415
– – 0.03% 171
2023
Q4 		$242K Buy
415
+15
+4% +$8.76K 0.03% 203
2023
Q3 		$215K Sell
400
-415
-51% -$214K 0.03% 217
2023
Q2 		$382K Buy
+815
New +$342K 0.04% 150

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Levin Capital Strategies's LLY Position: Q2 2024 in Review

Levin Capital Strategies sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 415 shares — an estimated $323K sold.

Levin Capital Strategies first reported a position in LLY in Q2 2023 and held it in 4 quarters. The position peaked at $382K in Q2 2023. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Levin Capital Strategies reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Levin Capital Strategies sold 415 Eli Lilly shares in Q2 2024, an estimated $323K.
  • Levin Capital Strategies first reported a position in Eli Lilly in Q2 2023 and held it in 4 quarters.
  • Levin Capital Strategies's Eli Lilly position peaked at $382K in Q2 2023.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Levin Capital Strategies's 13F filing for Q2 2024, filed 7 Aug 2024.